Clerk of the House of Representatives
Legislative Resource Center
135 Cannon Building
Washington, DC 20515
http://lobbyingdisclosure.house.gov
Secretary of the Senate
Office of Public Records
232 Hart Building
Washington, DC 20510
http://www.senate.gov/lobby

LOBBYING REGISTRATION

Lobbying Disclosure Act of 1995 (Section 4)

Check One: New Registrant New Client for Existing Registrant Amendment

1. Effective Date of Registration
05/19/2008
2. House Identification
 34506
Senate Identification
 48793

REGISTRANT Organization/Lobbying Firm Self Employed Individual

3. Registrant Organization
ACADEMY OF MANAGED CARE PHARMACY
Address
100 NORTH PITT STREET, #400
Address2
City
ALEXANDRIA
State
VA
Zip
22314
Country
USA

4. Principal place of business (if different than line 3)

City
State
Zip
Country
5. Contact name and telephone number International Number
Contact
​Mr. William Hermelin
Telephone
​7036838416
E-mail
​bhermelin@amcp.org
6. General description of registrant’s business or activities
​Promotion of sound medication management principles and strategies.

CLIENT A Lobbying Firm is required to file a separate registration for each client. Organizations employing in-house lobbyists should check the box labeled “Self” and proceed to line 10. Self

7. Client name
​ACADEMY OF MANAGED CARE PHARMACY
Address
City
State
Zip
Country
​USA
8. Principal place of business (if different than line 7)
City
State
Zip
Country
9. General description of client’s business or activities

LOBBYISTS

10. Name of each individual who has acted or is expected to act as a lobbyist for the client identified on line 7. If any person listed in this section has served as a “covered executive branch official” or “covered legislative branch official” within twenty years of first acting as a lobbyist for the client, state the executive and/or legislative position(s) in which the person served.

Name Covered Official Position (if applicable)
First
Last
Suffix
​William (Bill) ​Hermelin
​Melissa ​Andel
​Ryan ​Day
​Lauren ​Fuller ​Chief Investigative Counsel, U.S. Senate Cmte. on Finance

LOBBYING ISSUES

11. General lobbying issue areas (Select all applicable codes).

​HCR
​MMM
​PHA

12. Specific lobbying issues (current and anticipated)

Proposed changes to the Medicare prescription drug benefit; adjustments to Medicaid prescription drug reimbursement rates; FDA issues, including establishment of a regulatory pathway for approval of "follow-on" biologic drug products, additional monitoring of direct-to-consumer advertisements of prescription drugs and additional agency funding; funding for comparative effectiveness research; health information technology/e-prescribing; importation of prescription drugs/counterfeit drugs


AFFILIATED ORGANIZATIONS

13. Is there an entity other than the client that contributes more than $5,000 to the lobbying activities of the registrant in a quarterly period and either participates in and/or in whole or in major part supervises or controls the registrant’s lobbying activities?

No --> Go to line 14. Yes --> Complete the rest of this section for each entity matching the criteria above, then proceed to line 14.

Internet Address:
Name Address Principal Place of Business
Street
City State/Province Zip Code Country
City
State
Country
City
State
Country
City
State
Country

FOREIGN ENTITIES

14. Is there any foreign entity

a) holds at least 20% equitable ownership in the client or any organization identified on line 13; or

b) directly or indirectly, in whole or in major part, plans, supervises, controls, directs, finances or subsidizes activities of the client or any organization identified on line 13; or

c) is an affiliate of the client or any organization identified on line 13 and has a direct interest in the outcome of the lobbying activity?

No --> Sign and date the registration. Yes --> Complete the rest of this section for each entity matching the criteria above, then sign the registration.

Address Ownership
Name Street Principal place of business Amount of contribution
City State/Province Country
(city and state or country) for lobbying activities

City
State
Country
%
City
State
Country
%

Signature
Digitally Signed By: William Hermelin, Director of Government Relations and General Counsel
Date
07/01/2008